Clinically Actionable Tumor-Associated Antigens in Prostate Cancer

Clinical trial NCT07597369 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07597369
Sponsor: Peking University First Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer Metastatic Prostate Cancer Metastatic Prostate Cancer (mCRPC)

Start date: 2026-01-01
Primary completion: 2029-01-01
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.